INTELLIA THERAPEUT revenue breakdown overview

INTELLIA THERAPEUT revenue for the last year amounted to 52.56 M CHF, the most of which — 52.56 M CHF — came from its highest performing source at the moment, Genome Editing-based Therapies, the year earlier bringing 30.54 M CHF. The greatest contribution to the revenue figure was made by United States — last year it brought INTELLIA THERAPEUT 52.56 M CHF, and the year before that — 30.54 M CHF.